IP Verse

Topical Compositions In The Form Of A Gel Containing A Particular Solubilised Retinoid - EP2854803

The patent EP2854803 was granted to Galderma Research on Aug 24, 2022. The application was originally filed on May 30, 2013 under application number EP13728696A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2854803

GALDERMA RESEARCH
Application Number
EP13728696A
Filing Date
May 30, 2013
Status
Patent Maintained As Amended
Jul 22, 2022
Grant Date
Aug 24, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMar 26, 2019HGFADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0826366
DESCRIPTIONEP0989846
DESCRIPTIONEP1831149
DESCRIPTIONUS5851538
INTERNATIONAL-SEARCH-REPORTFR2915682
INTERNATIONAL-SEARCH-REPORTWO2006066978
OPPOSITIONUS2010143445
OPPOSITIONWO2006066978
OPPOSITIONWO2008148968

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- STÜCKER, SKIN RES TECHNOL., (200205), vol. 8, no. 2, pages 133 - 40
DESCRIPTION- THIELITZ, AM J CLIN DERMATOL., (2008), vol. 9, no. 6, pages 369 - 81
OPPOSITION- "Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris", Clinical Trials.gov, (20150922), URL: https://clinicaltrials.gov/ct2/show/NCT02556788, XP055580449
OPPOSITION- Extract from www.clinicaltrials.Gov/ct2/show/NCT02556788
OPPOSITION- GALDERMA R&D, "Clinical Study Synopsis for Public Disclosure", clinical trial sreqister, (20110000), URL: https://www.clin icaltrialsreq ister. eu/ctr -search/trial/20 1 0-024214 -54/resu lts, XP055580439
OPPOSITION- GALDERMA R&D, "PI LDT STUDY TD EXPLDRE EFFICACY AND SAFETI OF DIFFERENT DOSE REGIMENS OF CD5789 IN SUBJECTS WITH ACNE VULGARIS", clinical trials register, (20100923), URL: https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022211-19/ DE, XP055580446
OPPOSITION- GALDERMA R&D SNC, "EXPLDRATDRY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD5789 IN SUBJECTS WITH ACNE", Clinical trials Register, (20090317), URL: https://www.clinicaltrialsreqister.eu/ctr-search/trial/2008-007981-44/ FR, XP055580433
OPPOSITION- GALDERMA R&D SNC, "Exploratory study to assess facial tolerability after daily application of several concentrations and formulations containingCD5789 in acne subjects", Clinical trials Register, (20110214), URL: https://www.clinicaltrialsreqister.eu/ctr-search/trial/2010-024214-54/ BE, XP055580434

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents